Thrombotic risk in the antiphospholipid syndrome
W Lim - Seminars in thrombosis and hemostasis, 2014 - thieme-connect.com
The antiphospholipid syndrome (APS) is characterized by venous or arterial thrombosis
and/or pregnancy morbidity in patients with persistent presence of antiphospholipid …
and/or pregnancy morbidity in patients with persistent presence of antiphospholipid …
Antiphospholipid syndrome
W Lim - Hematology 2013, the American Society of Hematology …, 2013 - ashpublications.org
The antiphospholipid syndrome (APS) is defined by venous or arterial thrombosis and/or
pregnancy morbidity in patients with persistent presence of antiphospholipid antibodies …
pregnancy morbidity in patients with persistent presence of antiphospholipid antibodies …
Antiphospholipid syndrome: an evolving story
B Robertson, M Greaves - Blood reviews, 2006 - Elsevier
Antiphospholipid Syndrome (APS) is a form of immune mediated thrombophilia, presenting
as recurrent thrombotic events and pregnancy morbidity, in association with positive …
as recurrent thrombotic events and pregnancy morbidity, in association with positive …
Prevention and treatment of thrombotic antiphospholipid syndrome
M Crowther, KJ Legault, DA Garcia… - … research highlights and …, 2017 - Springer
Antiphospholipid syndrome (APS) is a clinical syndrome characterized by macro-and/or
microvascular thrombosis and pregnancy morbidity, with laboratory criteria including …
microvascular thrombosis and pregnancy morbidity, with laboratory criteria including …
What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts?
V Pengo, A Banzato, E Bison, A Bracco… - … in thrombosis and …, 2012 - thieme-connect.com
Venous or arterial thrombosis or pregnancy morbidity in the presence of circulating
antiphospholipid antibodies (aPL) define the antiphospholipid syndrome (APS). In terms of …
antiphospholipid antibodies (aPL) define the antiphospholipid syndrome (APS). In terms of …
[HTML][HTML] Management of thrombotic antiphospholipid syndrome
CB Chighizola, MG Raimondo… - Seminars in thrombosis …, 2018 - thieme-connect.com
Persistent serum positivity for antiphospholipid antibodies (aPL) is required to diagnose
antiphospholipid syndrome (APS), an autoimmune disease characterized by recurrent …
antiphospholipid syndrome (APS), an autoimmune disease characterized by recurrent …
Management of antiphospholipid syndrome
JI Tuthill, MA Khamashta - Journal of autoimmunity, 2009 - Elsevier
Antiphospholipid syndrome (APS) is characterised by vascular thrombosis and/or obstetric
morbidity in the presence of persistently positive antiphospholipid antibodies (aPL) …
morbidity in the presence of persistently positive antiphospholipid antibodies (aPL) …
Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies …
E Coloma Bazán, C Donate López… - Immunologic …, 2013 - Springer
Recommended treatment for patients with primary antiphospholipid syndrome (APS) after a
thrombotic event is long-term anticoagulation. Few patients with APS and previously positive …
thrombotic event is long-term anticoagulation. Few patients with APS and previously positive …
Antiphospholipid antibody syndrome
E Cucurull, AE Gharavi, Y Menon… - Current Treatment Options …, 2003 - Springer
Opinion statement Antiphospholipid antibody syndrome (APS) is a recently defined
autoimmune disorder characterized by recurrent vascular thromboses or recurrent …
autoimmune disorder characterized by recurrent vascular thromboses or recurrent …
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at …
G Ruiz-Irastorza, MJ Cuadrado, I Ruiz-Arruza… - Lupus, 2011 - journals.sagepub.com
The antiphospholipid syndrome (APS) is defined by the presence of thrombosis and/or
pregnancy morbidity in combination with the persistent presence of circulating …
pregnancy morbidity in combination with the persistent presence of circulating …